Current Month 2006
Article Features
  Aromatase Inhibitors Improve Survival in Advanced Breast Cancer
Suspicion Lingers Over Bisphenol A and Breast Cancer
Breast Density Helps Predict Breast Cancer Risk
Cell Regulating Gene May Predict Survival Outcomes for Breast Cancer Patients
Scientists Explain Cancer Cell Metabolism Changes
Protein Found That Protects Breast Cancer Tumors from Chemotherapy
Community Health Advisors Improve Women's Use of Mammography
Dartmouth Research Points to Protein S14 in Treating Breast Cancer
Gene Signature Assesses Breast Cancer Outcomes
Breast Discomfort During Hormone Therapy May Indicate Increased Risk for Breast Cancer
MRI More Accurately Determines Cancer Spread Into Breast Ducts
New Objective Criteria Improve PET Scan Reliability in Detecting Breast Cancer Metastasis
Raloxifene Reduces Breast Cancer Risk in Postmenopausal Women at All Risk Levels

Genome Code Cracked for Breast and Colon Cancers

Johns Hopkins Kimmel Cancer Center scientists have completed the first draft of the genetic code for breast and colon cancers. Their report, published online in the journal Science Express, identifies close to 200 mutated genes, now linked to these cancers, most of which were not previously recognized as associated with tumor initiation, growth, spread or control.

"Just as sequencing the human genome laid the groundwork for subsequent research in genetics, these data lay the foundation for decades of research on colon and breast cancers," says Victor Velculescu, M.D., Ph.D., assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center.

Although gene discoveries by independent scientists scattered around the world have provided clues, Velculescu says relatively few genes have been shown to be altered in cancers. The Hopkins gene hunters say the number of genes that were altered in breast and colorectal cancer genomes surprised them. "We expected to find a handful of genes, not 200," says Tobias Sj÷blom, a lead author and postdoctoral fellow at Hopkins' Kimmel Cancer Center.

Despite the potential rewards envisioned by cancer biologists, efforts to map cancer genes have drawn criticism from others who say that funding dollars should be spent on projects yielding more immediate benefits for detection and treatment.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon